Exhibit 10.28
Turning Point Therapeutics, Inc.
February 16, 2022
Annette North
Executive Vice President and General Counsel
Re: Transition Consulting Agreement
Dear Annette:
This letter sets forth the terms of the transition consulting agreement (the “Consulting Agreement”) that Turning Point Therapeutics, Inc. (the “Company”) is offering to you in connection with your resignation from the Company effective as of March 4, 2022 (“Separation Date”).
If this Consulting Agreement is acceptable to you, please sign below and return the fully signed original to me.
Sincerely,
TURNING POINT THERAPEUTICS, INC.
By: /s/ Athena Countouriotis
Athena Countouriotis, M.D.
President, Chief Executive Officer
Exhibit A - Confidentiality Agreement
AGREED:
/s/ Annette North
Annette North
Date: February 17, 2022
EXHIBIT A
CONFIDENTIALITY AGREEMENT